論文題目：Is better hypertension management buyable? - Evidence on hypertension treatment, education and control from China Health and Retirement Longitudinal Study
主講人：黃志勇
主持人：潘峣
評議人：苗雙有
時間：2021年6月25日 12:00-14:00
地點：文泉樓南207
摘要：In 2009, China launched a major healthcare reform that quadrupled government funding for health and pledged to provide equal access to basic health care for all citizens, with reasonable quality and financial risk protection. However, there are still widespread gaps in universal health coverage in China, such as the quality of care, control of non-communicable diseases, delivery efficiency, health expenditure control and public satisfaction. One of the challenges that universal health coverage in China faces is the poor performance in control of risk factors such as hypertension. In China, hypertension, with high and increasing prevalence and as a leading cause of premature death, has become a serious public health concern. We study the causal effect of government health expenditure on hypertension management using data collected in three waves of the China Health and Retirement Longitudinal Study (CHARLS) in 2011, 2013, and 2015. In this study, we use prefecture-level government health expenditure as the measure of public resources invested in hypertension management. Our analysis suggests that raise of government health expenditure in the new healthcare reform since 2009 cause a better hypertension management on medication treatment and patient education for urban males in China but not in other groups.
主講人簡介：
黃志勇，瑞士洛桑大學經濟學博士、西南财經大學公共管理學院副教授（已長聘）、北京大學中國衛生經濟研究中心訪問研究員、西南财經大學健康發展研究院副院長、四川省藥學會藥物經濟委員會委員、四川省醫保局醫療保障專家庫成員。在《Assessment》、《Community Mental Health J》、《Finance Research Letters》等SSCI期刊發表論文6篇，主持國家自然科學基金青年項目1項，作為副主編參編“十三五”國家重點圖書出版規劃項目1項。
電話：13281274386
個人項目主頁：http://socdata_admin.gitee.io/resume/
主要研究方向：
健康大數據分析（理論、應用、治理）
政策文本大數據分析（理論，應用、治理）
健康經濟學（人群健康、政策政策、衛生經濟評價）